Ibrutinib failure as a result of progressive CLL or Richter's Transformation

[bkoffman]

This week I'm posting another interview that took place at ASH 2016 with Dr. Adrian Wiestner from the NIH where we discussed ibrutinib failure as a result of progressive CLL or Richter's Transformation. You can view my summary, and watch the interview here: cllsociety.org/2017/06/ibru...

We have posted interviews and articles about research that is being conducted to study treatment options for patients with relapsed or refractory CLL. On occasion we will make our readers of a clinical trial that is starting that might be of interest. Today we have posted some information about a trial for patients with relapsed refractory CLL who have received 2 or more prior treatments, including treatment with a BTK inhibitor such as ibrutinib or acalabrutinib. You can read more about it here: cllsociety.org/2017/06/new-...

Stay strong

We are all in this together

Brian

[Justasheet1]

Doc,

Great interview with Dr Wiestner from the NIH. I have the utmost respect for you both.

Jeff

[cllady01 Former Volunteer]

Thank you. I have a better understanding of how/why RS can happen.